191 related articles for article (PubMed ID: 29981048)
1. Aptamers that bind to the human complement component receptor hC5aR1 interfere with hC5aR1 interaction to its hC5a ligand.
Kumar PKR
Mol Biol Rep; 2018 Oct; 45(5):851-864. PubMed ID: 29981048
[TBL] [Abstract][Full Text] [Related]
2. Effective suppression of C5a-induced proinflammatory response using anti-human C5a repebody.
Hwang DE; Choi JM; Yang CS; Lee JJ; Heu W; Jo EK; Kim HS
Biochem Biophys Res Commun; 2016 Sep; 477(4):1072-1077. PubMed ID: 27416759
[TBL] [Abstract][Full Text] [Related]
3. Structure and characterization of a high affinity C5a monoclonal antibody that blocks binding to C5aR1 and C5aR2 receptors.
Colley CS; Popovic B; Sridharan S; Debreczeni JE; Hargeaves D; Fung M; An LL; Edwards B; Arnold J; England E; Eghobamien L; Sivars U; Flavell L; Renshaw J; Wickson K; Warrener P; Zha J; Bonnell J; Woods R; Wilkinson T; Dobson C; Vaughan TJ
MAbs; 2018 Jan; 10(1):104-117. PubMed ID: 28952876
[TBL] [Abstract][Full Text] [Related]
4. Pharmacological characterisation of small molecule C5aR1 inhibitors in human cells reveals biased activities for signalling and function.
Li XX; Lee JD; Massey NL; Guan C; Robertson AAB; Clark RJ; Woodruff TM
Biochem Pharmacol; 2020 Oct; 180():114156. PubMed ID: 32682759
[TBL] [Abstract][Full Text] [Related]
5. Mutation of glutamate 199 of the human C5a receptor defines a binding site for ligand distinct from the receptor N terminus.
Monk PN; Barker MD; Partridge LJ; Pease JE
J Biol Chem; 1995 Jul; 270(28):16625-9. PubMed ID: 7622471
[TBL] [Abstract][Full Text] [Related]
6. The critical role of C5a as an initiator of neutrophil-mediated autoimmune inflammation of the joint and skin.
Sadik CD; Miyabe Y; Sezin T; Luster AD
Semin Immunol; 2018 Jun; 37():21-29. PubMed ID: 29602515
[TBL] [Abstract][Full Text] [Related]
7. Development of Synthetic Human and Mouse C5a: Application to Binding and Functional Assays
Gorman DM; Li XX; Payne CD; Cui CS; Lee JD; Rosengren KJ; Woodruff TM; Clark RJ
ACS Pharmacol Transl Sci; 2021 Dec; 4(6):1808-1817. PubMed ID: 34927012
[TBL] [Abstract][Full Text] [Related]
8. Role of the C5a-C5a receptor axis in the inflammatory responses of the lungs after experimental polytrauma and hemorrhagic shock.
Chakraborty S; Winkelmann VE; Braumüller S; Palmer A; Schultze A; Klohs B; Ignatius A; Vater A; Fauler M; Frick M; Huber-Lang M
Sci Rep; 2021 Jan; 11(1):2158. PubMed ID: 33495506
[TBL] [Abstract][Full Text] [Related]
9. Discovery of functionally selective C5aR2 ligands: novel modulators of C5a signalling.
Croker DE; Monk PN; Halai R; Kaeslin G; Schofield Z; Wu MC; Clark RJ; Blaskovich MA; Morikis D; Floudas CA; Cooper MA; Woodruff TM
Immunol Cell Biol; 2016 Sep; 94(8):787-95. PubMed ID: 27108698
[TBL] [Abstract][Full Text] [Related]
10. Structural basis for the targeting of complement anaphylatoxin C5a using a mixed L-RNA/L-DNA aptamer.
Yatime L; Maasch C; Hoehlig K; Klussmann S; Andersen GR; Vater A
Nat Commun; 2015 Apr; 6():6481. PubMed ID: 25901944
[TBL] [Abstract][Full Text] [Related]
11. Partial ligand-receptor engagement yields functional bias at the human complement receptor, C5aR1.
Pandey S; Li XX; Srivastava A; Baidya M; Kumari P; Dwivedi H; Chaturvedi M; Ghosh E; Woodruff TM; Shukla AK
J Biol Chem; 2019 Jun; 294(24):9416-9429. PubMed ID: 31036565
[TBL] [Abstract][Full Text] [Related]
12. Modeling molecular mechanisms of binding of the anaphylatoxin C5a to the C5a receptor.
Nikiforovich GV; Marshall GR; Baranski TJ
Biochemistry; 2008 Mar; 47(10):3117-30. PubMed ID: 18275159
[TBL] [Abstract][Full Text] [Related]
13. Netrin-1 Reduces Monocyte and Macrophage Chemotaxis towards the Complement Component C5a.
Taylor L; Brodermann MH; McCaffary D; Iqbal AJ; Greaves DR
PLoS One; 2016; 11(8):e0160685. PubMed ID: 27509208
[TBL] [Abstract][Full Text] [Related]
14. Anaphylatoxin receptor promiscuity for commonly used complement C5a peptide agonists.
Li XX; Clark RJ; Woodruff TM
Int Immunopharmacol; 2021 Nov; 100():108074. PubMed ID: 34454293
[TBL] [Abstract][Full Text] [Related]
15. Functional Analysis of a Novel Complement C5a Receptor 1-Blocking Monoclonal Antibody.
Cyranka L; Mariegaard I; Skjødt MO; Bayarri-Olmos R; Mollnes TE; Garred P; Rosbjerg A
J Innate Immun; 2023; 15(1):836-849. PubMed ID: 37952515
[TBL] [Abstract][Full Text] [Related]
16. Structure of the complement C5a receptor bound to the extra-helical antagonist NDT9513727.
Robertson N; Rappas M; Doré AS; Brown J; Bottegoni G; Koglin M; Cansfield J; Jazayeri A; Cooke RM; Marshall FH
Nature; 2018 Jan; 553(7686):111-114. PubMed ID: 29300009
[TBL] [Abstract][Full Text] [Related]
17. Development of Potent and Selective Agonists for Complement C5a Receptor 1 with In Vivo Activity.
Gorman DM; Li XX; Lee JD; Fung JN; Cui CS; Lee HS; Rolfe BE; Woodruff TM; Clark RJ
J Med Chem; 2021 Nov; 64(22):16598-16608. PubMed ID: 34762432
[TBL] [Abstract][Full Text] [Related]
18. Complement C5a Induces Pro-inflammatory Microvesicle Shedding in Severely Injured Patients.
Karasu E; Demmelmaier J; Kellermann S; Holzmann K; Köhl J; Schmidt CQ; Kalbitz M; Gebhard F; Huber-Lang MS; Halbgebauer R
Front Immunol; 2020; 11():1789. PubMed ID: 32983087
[TBL] [Abstract][Full Text] [Related]
19. Use of capillary electrophoresis to select a DNA aptamer that recognizes swine anaphylatoxin C5a.
Li Z; Wang X; Chen M; Li Q; Qu H; Shao T; Sun R; Zhang Y; Xia Z
Anal Biochem; 2019 Jan; 564-565():47-53. PubMed ID: 30336124
[TBL] [Abstract][Full Text] [Related]
20. Residues 10-18 within the C5a receptor N terminus compose a binding domain for chemotaxis inhibitory protein of Staphylococcus aureus.
Postma B; Kleibeuker W; Poppelier MJ; Boonstra M; Van Kessel KP; Van Strijp JA; de Haas CJ
J Biol Chem; 2005 Jan; 280(3):2020-7. PubMed ID: 15542591
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
